🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, global, Phase 2, open-label, 2-part, first-line stud...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center
Start Date
2019-08-29
Trial ID
NCT03929666
This multicenter, open-label, single-arm trial will evaluate the anti-tumor...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2020-10-01
Trial ID
NCT04466891
Treatments Being Tested
This is an open-label, multicenter, extension study to evaluate the long-te...
Status
Completed
Location
Mount Sinai Medical Center Braman Comprehensive Cancer Center
Start Date
2019-12-19
Trial ID
NCT04164199
I-SPY Phase I/Ib (I-SPY-P1) is an open-label, multisite platform study desi...
Status
Recruiting
Location
The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center
Start Date
2023-02-15
Trial ID
NCT05868226
Treatments Being Tested
This is a multicenter, Phase 2a, open-label, 2-part study to investigate th...
Status
Completed
Location
UCLA Hematology/Oncology Parkside
Start Date
2020-06-10
Trial ID
NCT04224272
Treatments Being Tested
This is an intermediate-size Expanded Access Protocol (EAP) for use of zani...
Status
No Longer Available
Location
NoCo Banner MD Anderson Cancer Center
Start Date
TBD
Trial ID
NCT04578444
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of zanidat...
Status
Recruiting
Location
Arizona Oncology Associates, PC - NAHOA
Start Date
2025-01-14
Trial ID
NCT06695845
Treatments Being Tested
This study is being done to find out if zanidatamab, when given with chemot...
Status
Active Not Recruiting
Location
Hospital de Gastroenterología Dr Bonorino Udaondo
Start Date
2021-12-02
Trial ID
NCT05152147
Treatments Being Tested
This is a Phase 2, single-site, single-arm open-label trial of zanidatamab ...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-11-16
Trial ID
NCT05035836
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Zanidat...
Status
Recruiting
Location
City of Hope(City of Hope National Medical Center, City of Hope Medical Center)
Start Date
2024-07-19
Trial ID
NCT06282575
Treatments Being Tested